Biopharmaceutical firm Bharat Serums and Vaccines (BSV) will set up an injectable and vaccine manufacturing facility at Genome Valley, near Hyderabad, with an investment of ₹200 crore.
Women health products, rabies vaccines, immunoglobulins and hormones among others will be manufactured at the state-of the art facility, managing director and CEO Sanjiv Navangul said on the proposed investment and facility after meeting Industries Minister K.T.Rama Rao here on Tuesday.
Announcing the entry of Bharat Serums in Genome Valley, the Minister said the move further highlights the strength of the life sciences sector in Telangana. The State is known as the vaccine capital of the world and life sciences capital of the country. “Government of Telangana will extend all support required by Bharat Serums and will also partner with BSV in areas like improving women’s health,” Mr. Rama Rao said.
